Novavax Inc (NVAX)
8.28
-0.19
(-2.24%)
USD |
NASDAQ |
Dec 27, 16:00
8.28
0.00 (0.00%)
After-Hours: 20:00
Novavax Research and Development Expense (Annual): 737.50M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Pfizer Inc | 10.68B |
Moderna Inc | 4.845B |
Inovio Pharmaceuticals Inc | 86.68M |
Baxter International Inc | 667.00M |
Halozyme Therapeutics Inc | 76.36M |